Analysts' Watchlist 2013

AI-Powered Healthcare Co. Gains Traction as US Expansion Accelerates
Source: John Newell (12/08/2025)

John Newell of John Newell & Associates shares why he thinks Rocket Doctor AI (AIDR:CSE; TREIF:OTC; 939:FRA) is a Speculative Buy.

read more >

Clean Tech Co.'s 'Forever Chemicals' Solution Featured in Industry Magazine
Source: Streetwise Reports (12/08/2025)

BioLargo Inc. (BLGO:OTCQX) subsidiary BioLargo Equipment Solutions & Technologies Inc. (BEST) is prominently featured in Chemical Engineering magazine for its advancements in electrostatic PFAS treatment technology. Find out why one expert likes this stock long-term.

read more >

Data on 2 Drugs, Identified Via AI, Shared at Conference
Source: Dr. Douglas Loe (12/04/2025)

Rakovina Therapeutics Inc.'s (RKV:TSX.V) preclinical ATR inhibitors, Compound A and Compound C, exhibit similarities to two clinical-stage drugs in the same class, noted a Leede Financial Inc. report.

read more >

Water Treatment Firm Finds High-Performance Solution for $2.99B PFAS Market
Source: Streetwise Reports (12/03/2025)

Chemical Engineering magazine features BioLargo Inc. (OTCQX:BLGO) subsidiary BioLargo Equipment Solutions & Technologies Inc. (BEST) for its advancements in electrostatic PFAS treatment technology. Read why one expert likes this stock long-term.

read more >

AI Breakthroughs Drive New Momentum in Oncology Research
Source: Streetwise Reports (12/03/2025)

Rakovina Therapeutics Inc. (RKV:TSX.V) reported financial and operational results for Q3, detailing continued progress across its AI-enabled DNA Damage Response programs. The company highlighted new scientific data, expanded collaborations, and increased visibility at major oncology conferences.

read more >